BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31713108)

  • 21. Vitamin E-induced coagulopathy in a young patient: a case report.
    Abrol R; Kaushik R; Goel D; Sama S; Kaushik RM; Kala M
    J Med Case Rep; 2023 Mar; 17(1):107. PubMed ID: 36949518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
    Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the clinical characteristics of tigecycline-induced hypofibrinogenemia.
    Lei H; Liu X; Li Z; Wang C
    J Chemother; 2023 Jul; 35(4):292-297. PubMed ID: 35904191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latamoxef induced a severe coagulation disorder in older patients in China: Two case reports.
    Zhu Y; Shen J; Wu W; Sun X; Hu X
    J Clin Pharm Ther; 2021 Feb; 46(1):227-229. PubMed ID: 32949406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tigecycline versus INR increase; more than expected?
    Akdağ D; Işıkgöz-Taşbakan M; Pullukcu H; Sipahi H; Sipahi OR
    Expert Opin Drug Saf; 2020 Mar; 19(3):335-337. PubMed ID: 31994416
    [No Abstract]   [Full Text] [Related]  

  • 26. Tigecycline-induced acute pancreatitis in a renal transplant patient: a case report and literature review.
    Lin J; Wang R; Chen J
    BMC Infect Dis; 2018 May; 18(1):201. PubMed ID: 29720098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coagulation abnormalities induced by beta-lactam antibiotics in cancer patients.
    Fainstein V; Bodey GP; McCredie KB; Keating MJ; Estey EH; Bolivar R; Elting L
    J Infect Dis; 1983 Oct; 148(4):745-50. PubMed ID: 6631064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study.
    Lin C; Tan M; Wang D; Gu C; Wu Y; Wang S
    Pharmacology; 2023; 108(6):540-549. PubMed ID: 37751720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tigecycline-induced coagulopathy: a literature review.
    Hakeam HA; Al Duhailib Z
    Int J Clin Pharm; 2020 Jun; 42(3):846-847. PubMed ID: 32219684
    [No Abstract]   [Full Text] [Related]  

  • 30. Tigecycline-Induced Severe Hypoglycemia in a Non-Diabetic Individual: A Case Report and Brief Review of Tigecycline-Induced Severe Hypoglycemia.
    Ray A; Sharma S; Atal S; Sadasivam B; Jhaj R
    Am J Case Rep; 2020 Jul; 21():e924556. PubMed ID: 32667905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coagulopathy and bleeding associated with salicylate toxicity.
    Hatten BW; Hendrickson RG
    Clin Toxicol (Phila); 2020 Jan; 58(1):16-19. PubMed ID: 30900477
    [No Abstract]   [Full Text] [Related]  

  • 32. Progression of Fibrinogen Decrease during High Dose Tigecycline Therapy in Critically Ill Patients: A Retrospective Analysis.
    Treml B; Rajsic S; Hell T; Fries D; Bachler M
    J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy.
    Winstedt D; Hanna J; Schött U
    Scand J Clin Lab Invest; 2013 Mar; 73(2):161-9. PubMed ID: 23368782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose fibrinogen versus a clinically recommended dose of fresh frozen plasma for reversal of dilutional coagulopathy in an in vitro model of severe hemodilution.
    Rosenthal C; Rau J; Volk T; Sander M; Ziemer S; Von Heymann C
    Minerva Anestesiol; 2014 Aug; 80(8):894-903. PubMed ID: 24398441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early coagulopathy at hospital admission predicts initial or delayed fibrinogen deficit in severe trauma patients.
    Deras P; Villiet M; Manzanera J; Latry P; Schved JF; Capdevila X; Charbit J
    J Trauma Acute Care Surg; 2014 Sep; 77(3):433-40. PubMed ID: 25159247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study.
    Firat O; Kara E; Malkan ÜY; Demirkan K; Inkaya AÇ
    Thromb Res; 2024 Apr; 236():155-160. PubMed ID: 38452447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulopathy in Zellweger spectrum disorders: a role for vitamin K.
    Zeynelabidin S; Klouwer FCC; Meijers JCM; Suijker MH; Engelen M; Poll-The BT; van Ommen CH
    J Inherit Metab Dis; 2018 Mar; 41(2):249-255. PubMed ID: 29139025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between standard laboratory and functional tests of coagulation in dilutional coagulopathy: an in vitro study.
    Krzych LJ; Czempik PF
    J Physiol Pharmacol; 2017 Aug; 68(4):637-645. PubMed ID: 29151081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy.
    Hanna J; Winstedt D; Schött U
    Scand J Clin Lab Invest; 2013 Oct; 73(7):553-62. PubMed ID: 24004348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the protein C pathway and endothelial glycocalyx shedding is associated with coagulopathy in an ovine model of trauma and hemorrhage.
    van Zyl N; Milford EM; Diab S; Dunster K; McGiffin P; Rayner SG; Staib A; Reade MC; Fraser JF
    J Trauma Acute Care Surg; 2016 Oct; 81(4):674-84. PubMed ID: 27488493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.